| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Igor A. Sobenin | Q38323510 |
| Alexander Orekhov | Q51464003 | ||
| Yuri V Bobryshev | Q88065781 | ||
| P2093 | author name string | Dmitry A Chistiakov | |
| Emil Kozarov | |||
| P2860 | cites work | Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction | Q24291653 |
| Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease | Q24601951 | ||
| Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis | Q24629045 | ||
| LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor | Q24656186 | ||
| Has the microbiota played a critical role in the evolution of the adaptive immune system? | Q27098541 | ||
| An obesity-associated gut microbiome with increased capacity for energy harvest | Q27860515 | ||
| The gut microbiota as an environmental factor that regulates fat storage | Q28131676 | ||
| Potential mechanisms for the emerging link between obesity and increased intestinal permeability | Q28277563 | ||
| Metabolic endotoxemia initiates obesity and insulin resistance | Q29547720 | ||
| Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice | Q29615055 | ||
| Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability | Q29617378 | ||
| An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid | Q29620015 | ||
| Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). | Q31943019 | ||
| The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. | Q33670800 | ||
| The environment within: how gut microbiota may influence metabolism and body composition | Q33696549 | ||
| Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis | Q38308819 | ||
| A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha | Q38321742 | ||
| Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance | Q38335183 | ||
| Protocatechuic Acid, a Metabolite of Anthocyanins, Inhibits Monocyte Adhesion and Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice | Q39629911 | ||
| Chylomicrons promote intestinal absorption of lipopolysaccharides | Q39936075 | ||
| Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages | Q40212651 | ||
| Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity | Q41171975 | ||
| Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages | Q42435836 | ||
| Electron microscopic studies of the assembly, intracellular transport, and secretion of chylomicrons by rat intestine | Q42445015 | ||
| Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis | Q42641324 | ||
| Absence of microbiota (germ-free conditions) accelerates the atherosclerosis in ApoE-deficient mice fed standard low cholesterol diet | Q43105484 | ||
| Meat-loving microbes: do steak-eating bacteria promote atherosclerosis? | Q43490619 | ||
| Cyanidin-3-O-β-glucoside with the aid of its metabolite protocatechuic acid, reduces monocyte infiltration in apolipoprotein E-deficient mice | Q43501369 | ||
| Supplementation of cyanidin-3-O-β-glucoside promotes endothelial repair and prevents enhanced atherogenesis in diabetic apolipoprotein E-deficient mice | Q43584656 | ||
| Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways | Q44807760 | ||
| Energy intake is associated with endotoxemia in apparently healthy men. | Q45769895 | ||
| Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial diversity in colon: a randomized controlled trial. | Q45927692 | ||
| Modulation of the murine microbiome with a concomitant anti-obesity effect by Lactobacillus rhamnosus GG and Lactobacillus sakei NR28. | Q53387154 | ||
| Effect of Lactobacillus delbrueckii on cholesterol metabolism in germ-free mice and on atherogenesis in apolipoprotein E knock-out mice | Q58227619 | ||
| Cyanidin-3-O-β-glucoside upregulates hepatic cholesterol 7α-hydroxylase expression and reduces hypercholesterolemia in mice | Q83865804 | ||
| Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b | Q84598091 | ||
| Lipopolysaccharide regulates MMP-9 expression through TLR4/NF-κB signaling in human arterial smooth muscle cells | Q84654958 | ||
| Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall | Q85054596 | ||
| Cyanidin-3-O-β-glucoside ameliorates lipopolysaccharide-induced acute lung injury by reducing TLR4 recruitment into lipid rafts | Q87907415 | ||
| Molecular and cellular mechanisms responsible for cellular stress and low-grade inflammation induced by a super-low dose of endotoxin | Q33718511 | ||
| The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2. | Q33924208 | ||
| Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers | Q34160803 | ||
| VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation | Q34428997 | ||
| Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice | Q34555906 | ||
| Myeloid differentiation primary response protein 88 couples reverse cholesterol transport to inflammation | Q34966302 | ||
| Regulation of innate and adaptive immunity by the commensal microbiota | Q35028444 | ||
| Endotoxemia of metabolic syndrome: a pivotal mediator of meta-inflammation | Q35233030 | ||
| Does the microbiota regulate immune responses outside the gut? | Q35946273 | ||
| Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide | Q36084187 | ||
| An antiatherosclerotic signaling cascade involving intestinal microbiota, microRNA-10b, and ABCA1/ABCG1-mediated reverse cholesterol transport | Q36361743 | ||
| Liver X receptors as integrators of metabolic and inflammatory signaling | Q36411128 | ||
| Molecular mechanisms responsible for the reduced expression of cholesterol transporters from macrophages by low-dose endotoxin | Q36534100 | ||
| Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E | Q36986664 | ||
| LXR signaling couples sterol metabolism to proliferation in the acquired immune response. | Q37061238 | ||
| HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis | Q37156017 | ||
| Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders | Q37633342 | ||
| Gut microbiota and probiotics in modulation of epithelium and gut-associated lymphoid tissue function | Q37642855 | ||
| The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases | Q37729525 | ||
| Specificity of the adaptive immune response to the gut microbiota | Q37804996 | ||
| Host-bacterial symbiosis in health and disease | Q37805002 | ||
| Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism | Q37807066 | ||
| Current advances in understanding of immunopathology of atherosclerosis | Q37808645 | ||
| Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae | Q37848659 | ||
| Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation | Q37856309 | ||
| Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2. | Q37860795 | ||
| Diet and atherosclerosis in apolipoprotein E-deficient mice | Q37889038 | ||
| How the interplay between antigen presenting cells and microbiota tunes host immune responses in the gut. | Q37964150 | ||
| The interplay between the gut immune system and microbiota in health and disease: nutraceutical intervention for restoring intestinal homeostasis | Q38059756 | ||
| Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases | Q38078691 | ||
| The role of the gut in reverse cholesterol transport--focus on the enterocyte | Q38100882 | ||
| The Effect of High-Fat Diet-Induced Pathophysiological Changes in the Gut on Obesity: What Should be the Ideal Treatment? | Q38120639 | ||
| Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality? | Q38152155 | ||
| Bacterial colonization and intestinal mucosal barrier development | Q38254145 | ||
| The intestinal microbiota and microenvironment in liver | Q38260249 | ||
| A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways | Q38297619 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 671 | |
| P577 | publication date | 2015-06-30 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Role of gut microbiota in the modulation of atherosclerosis-associated immune response | |
| P478 | volume | 6 |
| Q91707045 | Gut Microbiota-Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target |
| Q90310328 | Gut microbiota and cardiovascular disease: opportunities and challenges |
| Q46227294 | Intermittent Hypoxia and Hypercapnia Accelerate Atherosclerosis, Partially via Trimethylamine-Oxide |
| Q61797279 | Lactobacillus mucosae DPC 6426 as a bile-modifying and immunomodulatory microbe |
| Q93379690 | Microbial impact on cholesterol and bile acid metabolism: current status and future prospects |
| Q37368775 | Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice |
| Q58121145 | New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis |
| Q89179213 | Non-coding RNAs in lipid metabolism |
| Q46312498 | Organ-specific protection mediated by cooperation between vascular and epithelial barriers. |
| Q37669694 | Porphyromonas gingivalis is the most abundant species detected in coronary and femoral arteries |
| Q47352791 | Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides |
| Q92240636 | Simultaneous Determination of Seven Active Components in Rat Plasma by UHPLC-MS/MS and Application to a Quantitative Study after Oral Administration of Huang-Lian Jie-Du Decoction in High Fat-Induced Atherosclerosis Rats |
| Q64927277 | The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy. |
| Q37374367 | The use of probiotic L. fermentum ME-3 containing Reg'Activ Cholesterol supplement for 4 weeks has a positive influence on blood lipoprotein profiles and inflammatory cytokines: an open-label preliminary study |
| Q39459129 | Trimethylamine N-oxide: breathe new life. |
| Q97899561 | Trimethylamine-N-Oxide: Heart of the microbiota-cardiovascular disease nexus? |
Search more.